title: Dual antiplatelet treatment in patients candidates for abdominal surgery.
abstract: With the increasing diffusion of percutaneous interventions (PCI), surgeons are often faced with the problem of operating on patients under dual antiplatelet treatment. Replacing dual antiplatelet regiment with low molecular weight heparin may expose to the abrupt thrombosis of coronary stent and massive myocardial infarction. The purpose of this study was to test the hypothesis that abdominal operations can be safely performed under dual antiplatelet treatment. Eleven patients underwent 5 colectomies, 3 nefrectomies, 2 gastrectomies and 1 hysterectomy under aspirin and plavix without any significant perioperative hemorrhage. These preliminary results show that abdominal operations can be safely performed under dual antiplatelet regimen.
  
  
  BACKGROUND
  Abdominal surgery, Dual antiplatelet treatment.
authors.affiliation: Francesco Durante Dept. of Surgery, University of Rome La Sapienza, Rome, Italy. giulio.illuminati@uniroma1.it
authors.forename: Giulio
authors.initials: G
authors.lastname: Illuminati
authors.forename: Gianluca
authors.initials: G
authors.lastname: Ceccanei
authors.forename: Maria A
authors.initials: MA
authors.lastname: Pacilè
authors.forename: Giulia
authors.initials: G
authors.lastname: Pizzardi
authors.forename: Piergaspare
authors.initials: P
authors.lastname: Palumbo
authors.forename: Francesco
authors.initials: F
authors.lastname: Vietri
mesh_terms: D000005:Abdomen / Q000601:surgery*; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012189:Retrospective Studies; D012307:Risk Factors; D013514:Surgical Procedures, Operative
chemical_list: D010975:Platelet Aggregation Inhibitors